Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 261 - 270 of 494 results

First page
Previous page
Next page
Next page

INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

0JXM8X6ZW8

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

Class:

STRUCTURALLY DIVERSE

HYDROLYZED SHEEP WOOL KERATIN (200 MW)

R6K7AW17SU

Status:

Possibly Marketed Outside US

Source:

M032

(2025)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f06bef8-257f-6a40-e063-6294a90a481f

First approved in 2016

Source:

M032

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aed49bfe-e016-46ac-a025-81b47cc08147

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

55QH9PJKDV

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

QIUVRYZMAH

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84452700-6f7b-4eec-af36-ee2e0f52f7f0

First approved in 2016

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84452700-6f7b-4eec-af36-ee2e0f52f7f0

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

41Q3TYMWV2

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

Class:

STRUCTURALLY DIVERSE

CLOSTRIDIUM BOTULINUM

0296055VE0

Status:

Possibly Marketed Outside US

Source:

Protoxin by Protox Inc.

Source URL:

https://www.drugbank.ca/drugs/DB14223

First approved in 2016

Source:

PROTOXIN by PROTOX Inc.

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=41280d2a-9231-5800-e054-00144ff88e88

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/HONG KONG/259/2010 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

56OC384IDL

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

Class:

STRUCTURALLY DIVERSE

ZOSTERA MARINA SEED

2H467I6F58

Status:

Possibly Marketed Outside US

Source:

21 CFR 352

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a95a782-006e-4bab-a909-33f9733209cf

First approved in 2016

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a95a782-006e-4bab-a909-33f9733209cf

Class:

STRUCTURALLY DIVERSE

ZOSTERA MARINA WHOLE

5JFW9Q62HN

Status:

Possibly Marketed Outside US

Source:

505G(a)(3)

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e56f5a94-0be1-487b-ad95-c1fe74c824ee

First approved in 2016

Source:

505G(a)(3)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e56f5a94-0be1-487b-ad95-c1fe74c824ee

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

9VVQ21KI5Z

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=337a837d-c87d-46f3-a019-12ca7d0a9bcb

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

HYDROLYZED SHEEP WOOL KERATIN (200 MW)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

CLOSTRIDIUM BOTULINUM

Structurally Diverse

INFLUENZA B VIRUS B/HONG KONG/259/2010 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

ZOSTERA MARINA SEED

Structurally Diverse

ZOSTERA MARINA WHOLE

Structurally Diverse

INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Showing 261 - 270 of 494 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1